• Molecular NameOxazepam
  • Synonymd-Oxazepam hemisuccinate; Oxazipam; Oxozepam
  • Weight286.718
  • Drugbank_IDDB00842
  • ACS_NO604-75-1
  • Show 2D model
  • LogP (experiment)2.24
  • LogP (predicted, AB/LogP v2.0)2.04
  • pka1.7, 11.6
  • LogD (pH=7, predicted)2.04
  • Solubility (experiment)0.0322 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-2.99
  • LogSw (predicted, AB/LogsW2.0)0.06
  • Sw (mg/ml) (predicted, ACD/Labs)0.3
  • No.of HBond Donors2
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds1
  • TPSA61.69
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyOxazepam has moderate amnesic, anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties compared to other benzodiazepines.
  • Absorption_value97.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability97.0
  • Protein binding87.0
  • Volume of distribution (VD)0.59 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmIn liver to inactive compounds (glucuronide conjugates).
  • Half life8 h
  • ExcretionRenal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityConfusion, drowsiness, lethargy.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A